Valuein

Overview

ALBEMARLE CORP

ALBNYSEMaterialsPlastic Materials, Synth Resins & Nonvulcan ElastomersCIK 0000915913Large-cap benchmark

Latest 10-K: FY2025, filed Feb 11, 2026 · Open the 10-K (Inline XBRL) ↗

Revenue
$5.14B
4.4%YoYdown from FY2024
TotalRevenue
Gross profit
$0.67B
969.3%YoYup from FY2024
GrossProfit
Operating income
-$0.37B
n/mYoY
OperatingIncome
Net income
-$0.51B
n/mYoY
NetIncome
Diluted EPS
-$5.76
n/mYoY
EPSDiluted
Diluted shares
117.7M
0.1%YoYup from FY2024
WeightedAvgSharesDiluted

At a glance

Growth

  • ALBEMARLE CORP reported revenue of $5.14B for fiscal 2025, down 4.4% from fiscal 2024.
  • Revenue grew faster than the median S&P 500 member in 2 of the last 5 fiscal years.

Profitability

  • Operating margin was -7.1% and net margin was -9.9%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.

Per share

  • Diluted EPS was -$5.76.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 30, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Revenue
$5.14B4.4%down
Benchmark median 6.4%
$5.38B44.1%down
Benchmark median 4.5%
$9.62B31.4%up
Benchmark median 4.8%
$7.32B120.0%up
Benchmark median 10.3%
$3.33B6.4%up
Benchmark median 13.8%
11.5%
Benchmark median 6.6%
Gross Profit
Median of 315 / 498
$0.67B969.3%up
Benchmark median 6.8%
$0.06B94.7%down
Benchmark median 5.5%
$1.19B61.4%down
Benchmark median 5.2%
$3.07B208.1%up
Benchmark median 8.3%
$1.00B0.3%up
Benchmark median 15.7%
-9.5%
Benchmark median 6.2%
Operating Income
Median of 373 / 498
negative: -$0.37Bn/m
Benchmark median 7.3%
negative: -$1.78B805.3%down
Benchmark median 7.4%
$0.25B89.8%down
Benchmark median 4.9%
$2.47B209.4%up
Benchmark median 7.5%
$0.80B57.9%up
Benchmark median 23.5%
n/m
Benchmark median 7.2%
Net Income
negative: -$0.51Bn/m
Benchmark median 4.8%
negative: -$1.18B175.0%down
Benchmark median 5.7%
$1.57B41.5%down
Benchmark median 1.9%
$2.69B2075.0%up
Benchmark median 1.3%
$0.12B67.1%down
Benchmark median 33.9%
n/m
Benchmark median 4.1%
EPS (Diluted)
negative: -$5.76n/m
Benchmark median 6.2%
negative: -$11.20183.8%down
Benchmark median 7.9%
$13.3641.5%down
Benchmark median 1.9%
$22.842054.7%up
Benchmark median 1.5%
$1.0669.9%down
Benchmark median 34.8%
n/m
Benchmark median 5.6%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Total Assets
$16.37B1.4%down
Benchmark median 5.6%
$16.61B9.1%down
Benchmark median 3.4%
$18.27B18.2%up
Benchmark median 4.1%
$15.46B40.8%up
Benchmark median 2.2%
$10.97B5.0%up
Benchmark median 6.7%
10.5%
Benchmark median 4.7%
Total Liabilities
Median of 357 / 498
—
—
—
—
—
—
Benchmark median 4.4%
Stockholders' Equity
$9.78B4.1%down
Benchmark median 6.8%
$10.20B5.5%up
Benchmark median 5.4%
$9.67B18.0%up
Benchmark median 7.3%
$8.19B41.1%up
Benchmark median 2.5%
$5.81B29.9%up
Benchmark median 9.0%
13.9%
Benchmark median 6.1%
Cash & Equivalents
—
—
—
—
—
—
Benchmark median 2.0%
Total Debt
$3.19B9.2%down
Benchmark median 2.1%
$3.52B15.6%down
Benchmark median 0.2%
$4.17B29.5%up
Benchmark median 0.3%
$3.22B34.4%up
Benchmark median 0.1%
$2.39B33.0%down
Benchmark median -0.1%
7.5%
Benchmark median 4.3%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Operating Cash Flow
$1.28B86.4%up
Benchmark median 6.3%
$0.69B48.1%down
Benchmark median 4.8%
$1.33B30.5%down
Benchmark median 9.9%
$1.91B454.2%up
Benchmark median -0.7%
$0.34B56.9%down
Benchmark median 10.7%
38.9%
Benchmark median 7.0%
Capital Expenditures
$0.59B64.9%down
Benchmark median 5.4%
$1.68B22.0%down
Benchmark median 2.8%
$2.15B70.8%up
Benchmark median 11.3%
$1.26B32.3%up
Benchmark median 14.0%
$0.95B12.1%up
Benchmark median 8.1%
-11.3%
Benchmark median 9.0%
Free Cash Flow
Median of 378 / 498
$692.47Mn/m
Benchmark median 7.3%
negative: -$992.65Mn/m
Benchmark median 6.1%
negative: -$827.96M228.1%down
Benchmark median 8.8%
$646.20Mn/m
Benchmark median -11.3%
negative: -$609.41Mn/m
Benchmark median 10.2%
n/m
Benchmark median 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

n/m

Wall Street

on net earnings

FY2024 n/m

4.2%

Value investor

on free cash flow

FY2024 negative: −9.8%

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E n/m

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on ALB yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ALB and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 30, 2026. Canonical address: https://valuein.biz/data/ALB

APA-style text
Valuein. (2026, October 30). ALBEMARLE CORP (ALB) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/ALB
BibTeX
@misc{valuein_alb_2026,
  author = {{Valuein}},
  title = {ALBEMARLE CORP (ALB) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/ALB}},
  note = {Data as of 2026-10-30; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed Feb 11, 2026 · accession 0000915913-26-000018

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.